01 March 2017
News and Views
Links and Services
A study in November's issue of the Alimentary Pharmacology & Therapeutics investigates telaprevir-based triple therapy for chronic Hepatitis C patients with advanced fibrosis.
Antiviral treatment is recommended for chronic hepatitis C patients with advanced fibrosis to red
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors